Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders (Q71854374)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

myeloproliferative disorders

21 October 2019

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

Sagripanti A

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Ferretti A

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Carpi A

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

Biomedicine and Pharmacotherapy

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

376-382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

Polycythemia vera: stem-cell and probable clonal origin of the disease

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Aspirin and risk of bleeding in patients with thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Essential thrombocythemias. Clinical evolutionary and biological data

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Complications and causes of death in polycythaemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Acute thrombotic complications of myeloproliferative disorders in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Clinical course of essential thrombocythemia in 147 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders: a retrospective study of 108 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Primary Thrombocythemia in Japan: A Survey of 225 Patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Essential thrombocythemia. Clinical characteristics and course of 61 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Neurologic manifestations of essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Uncontrolled thrombocytosis in chronic myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Arterial thrombosis in essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Essential thrombocythemia in young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Transient neurologic and ocular manifestations in primary thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Hemostatic complications in young patients with essential thrombocythemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Primary thrombocythaemia: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Essential Thrombocythaemia and Peripheral Gangrene

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

The significance of thrombocytosis in old age

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Deficiency of platelet lipoxygenase activity in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Anagrelide: A New Drug for Treating Thrombocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Microvascular Occlusive Lesions in Primary Thrombocythaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Primary thrombocythaemia treated with busulphan

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0753-3322%2896%2989672-7

7 January 2021

10.1016/S0753-3322(96)89672-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8952859%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference